← Back to All Stocks

Q32 Bio Inc. (QTTB) Analysis

Generated on: 2025-08-20 19:36:00 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
⚠️ VERY LOW FLOAT STOCK - 5,426,353 shares

Analysis Values

Current Price
$1.81
Predicted Price
$2.26
Expected Return
15.64%
Confidence Score
0.78
RSI (14)
36.77
MACD
-0.04
Volume
57,099
Float Shares
5,426,353
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
251

QTTB

Q32 Bio Inc.
15.64%
Price: $1.81
Confidence: 0.78
News
Low Float
Last updated: 2025-08-20 19:36:00

Technical Analysis

RSI: 36.77
MACD: -0.04
Technical Analysis Graph

Risk Analysis

Volatility
176.3%
Max Drawdown
-97.31%
Beta
1.0
Risk Score
100

Social Sentiment

0
Social Sentiment Score (0-100)

Recent News

News thumbnail
Oxford Biomedica completes acquisition of remaining stake in U.S. subsidiary
TipRanks - 2025-06-24 17:06
OXB has acquired the remaining 10% stake in its US subsidiary from Q32 Bio (QTTB), bringing its ownership, as planned, to 100%. As previously disclosed in the Company’s Preliminary Results on 9 April, OXB US exercised its call option on 1 March to acquire the final 10% interest in OXB US from Q32. The stake was originally held by Homology Medicines, which merged with Q32 in 2024. The transfer of Q32’s 10% holding to OXB US, means that OXB US is now wholly owned by OXB. OXB US was originally esta

Reddit Discussions

No recent Reddit discussions found.

Recent SEC Filings

No recent SEC filings found.